Clinical application of JAK inhibitors in SAPHO syndrome

Int J Rheum Dis. 2024 Aug;27(8):e15231. doi: 10.1111/1756-185X.15231.

Authors

Guiying Wu^{1

2}, Cheng Wang^{1

2}; Wrriliga^{1

2}; Yong Wang^{1

2}

Affiliations

¹ Department of Rheumatology and Immunology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
² Inner Mongolia Key Laboratory for Pathogenesis and Diagnosis of Rheumatic and Autoimmune Diseases, Hohhot, China.

PMID: 39082278
DOI: 10.1111/1756-185X.15231

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Acquired Hyperostosis Syndrome* / diagnosis
Acquired Hyperostosis Syndrome* / drug therapy
Adult
Female
Humans
Janus Kinase Inhibitors* / therapeutic use
Male
Middle Aged
Piperidines
Pyrimidines / therapeutic use
Treatment Outcome

Substances

Janus Kinase Inhibitors
Pyrimidines
tofacitinib
Piperidines

Grants and funding